BeyondSpring Inc. (BYSI)
BYSI Stock Price Chart
Explore BeyondSpring Inc. interactive price chart. Choose custom timeframes to analyze BYSI price movements and trends.
BYSI Company Profile
Discover essential business fundamentals and corporate details for BeyondSpring Inc. (BYSI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Mar 2017
Employees
40.00
CEO
Lan Huang
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.
BYSI Financial Timeline
Browse a chronological timeline of BeyondSpring Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.04 .
Earnings released on 12 May 2025
EPS came in at -$0.06 .
Earnings released on 27 Mar 2025
EPS came in at $0.08 , while revenue for the quarter reached -$1.44M .
Earnings released on 9 Aug 2024
EPS came in at -$0.09 , while revenue for the quarter reached $500.00K .
Earnings released on 29 Apr 2024
EPS came in at -$0.11 , while revenue for the quarter reached $438.00K , missing expectations by -98.54%.
Earnings released on 11 Apr 2024
EPS came in at -$0.09 , while revenue for the quarter reached $500.00K , missing expectations by -98.33%.
Earnings released on 28 Feb 2024
EPS came in at -$0.16 , while revenue for the quarter reached $437.50K , missing expectations by -98.54%.
Earnings released on 29 Sept 2023
EPS came in at -$0.11 , while revenue for the quarter reached $438.00K .
Earnings released on 18 Apr 2023
EPS came in at -$0.19 surpassing the estimated -$0.58 by +67.41%, while revenue for the quarter reached $337.50K , missing expectations by -98.88%.
Earnings released on 31 Mar 2023
EPS came in at -$0.16 , while revenue for the quarter reached $437.50K .
Earnings released on 28 Feb 2023
EPS came in at -$0.24 , while revenue for the quarter reached $338.00K , missing expectations by -0.59%.
Earnings released on 30 Sept 2022
EPS came in at -$0.19 surpassing the estimated -$0.23 by +17.81%, while revenue for the quarter reached $337.50K , missing expectations by -0.74%.
Earnings released on 14 Apr 2022
EPS came in at -$0.24 surpassing the estimated -$0.26 by +7.69%, while revenue for the quarter reached $338.00K , beating expectations by +25.88%.
Earnings released on 31 Mar 2022
EPS came in at -$0.24 , while revenue for the quarter reached $338.00K .
Earnings released on 30 Dec 2021
EPS came in at -$0.47 surpassing the estimated -$0.58 by +18.97%, while revenue for the quarter reached $337.00K , beating expectations by +98.24%.
Earnings released on 10 Sept 2021
EPS came in at -$0.49 matching the estimated -$0.49, while revenue for the quarter reached $338.00K , missing expectations by -96.14%.
Earnings released on 16 Jun 2021
EPS came in at -$0.44 surpassing the estimated -$0.54 by +18.52%, while revenue for the quarter reached $338.00K .
Earnings released on 30 Apr 2021
EPS came in at -$0.52 falling short of the estimated -$0.45 by -15.56%, while revenue for the quarter reached $180.00K .
Earnings released on 17 Nov 2020
EPS came in at -$0.48 surpassing the estimated -$0.54 by +11.11%.
BYSI Stock Performance
Access detailed BYSI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.